Second-quarter earnings more than doubled at US
health-care product maker Johnson & Johnson, the company said Monday.
Quarterly net income was 3.8 billion dollars, or 1.3 dollars a share. The New Jersey-based company attributed the higher earnings in part to the sale of its stake in Elan Corporation.
Revenue rose 8.5 per cent to 17.8 billion dollars year-on-year. Both earnings and revenue beat Wall Street's expectations, Bloomberg news reported.
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- Apple, HP, Intel May Take a Hit from Slowdown in Smartphone Sales Growth
- Keurig Adds Peet's coffee, Alters Starbucks deal
- U.S. to Relinquish Gov't Control Over Internet
- Quiznos Files for Chapter 11
- SoCalGas Reaches Record Spend on Diversity Suppliers
- Is Malaysian Airlines Flight 370 in Andaman Sea?
- Motley Crue's Nikki Sixx Marries Model Courtney Bingham
- Vybz Kartel Convicted of Murder